{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:52:12Z","timestamp":1790826732270,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:00:00Z","timestamp":1568937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center (Poland)","award":["UMO-2016\/21\/N\/NZ3\/03263"],"award-info":[{"award-number":["UMO-2016\/21\/N\/NZ3\/03263"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The HtrA4 human protease is crucial in placentation and embryo implantation, and its altered level is connected with pre-eclampsia. The meta-analyses of microarray assays revealed that the HtrA4 level is changed in brain tumors and breast and prostate cancers, which suggests its involvement in oncogenesis. In spite of the HtrA4 involvement in important physiological and pathological processes, its function in the cell is poorly understood. In this work, using lung and breast cancer cell lines, we showed for the first time that the full-length HtrA4 and its N-terminally deleted variant promote cancer cell death induced by chemotherapeutic drugs by enhancing apoptosis. The effect is dependent on the HtrA4 proteolytic activity, and the N-terminally deleted HtrA4 is more efficient in the cell death stimulation. Furthermore, HtrA4 increases the effect of chemotherapeutics on the clonogenic potential and motility of cancer cells, and it increases cell cycle arrest at the G2\/M phase. HtrA4 may modulate cell death by degrading the anti-apoptotic XIAP protein and also by proteolysis of the executioner pro-caspase 7 and cytoskeletal proteins, actin and \u03b2-tubulin. These findings provide new insight into the mechanism of the HtrA4 protease function in cell death and oncogenesis, and they may help to develop new anti-cancer therapeutic strategies.<\/jats:p>","DOI":"10.3390\/cells8101112","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T02:51:11Z","timestamp":1568947871000},"page":"1112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1927-9959","authenticated-orcid":false,"given":"Tomasz","family":"Wenta","sequence":"first","affiliation":[{"name":"Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Rychlowski","sequence":"additional","affiliation":[{"name":"Laboratory of Virus Molecular Biology, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-3555","authenticated-orcid":false,"given":"Miroslaw","family":"Jarzab","sequence":"additional","affiliation":[{"name":"Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lipinska","sequence":"additional","affiliation":[{"name":"Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA proteases: Regulated proteolysis in protein quality control","volume":"12","author":"Clausen","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","first-page":"977","article-title":"HtrA protease family as therapeutic targets","volume":"19","author":"Koper","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.abb.2017.04.004","article-title":"Structural insights into the activation mechanisms of human HtrA serine proteases","volume":"621","author":"Wenta","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1160\/TH12-06-0404","article-title":"Omi\/HtrA2 and XIAP are components of platelet apoptosis signalling","volume":"109","author":"Winkler","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuint.2006.07.018","article-title":"The serine protease Omi\/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia\/reperfusion","volume":"50","author":"Althaus","year":"2007","journal-title":"Neurochem. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ijc.26044","article-title":"HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation","volume":"130","author":"He","year":"2012","journal-title":"Int. J. Cancer."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopha.2014.12.044","article-title":"HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP","volume":"70","author":"Bao","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_9","first-page":"264","article-title":"HtrA1 Down-regulation Induces Cisplatin Resistance in Colon Cancer by Increasing XIAP and Activating PI3K\/Akt Pathway","volume":"47","author":"Xiong","year":"2017","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wenta, T., Rychlowski, M., Jurewicz, E., Jarzab, M., Zurawa-Janicka, D., Filipek, A., and Lipinska, B. (2019). The HtrA3 protease promotes drug-induced death of lung cancer cells by cleavage of the X-linked inhibitor of apoptosis protein (XIAP). FEBS J.","DOI":"10.1111\/febs.14977"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbapap.2017.06.013","article-title":"The role of the LB structural loop and its interactions with the PDZ domain of the human HtrA3 protease","volume":"1865","author":"Wenta","year":"2017","journal-title":"Biochim. Biophys. Acta Proteins Proteomics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1042\/BCJ20190224","article-title":"Discerning the Mechanism of Action of HtrA4: A Serine Protease Implicated in the Cell Death Pathway","volume":"476","author":"Kummari","year":"2019","journal-title":"Biochem. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Glaza, P., Osipiuk, J., Wenta, T., Zurawa-Janicka, D., Jarzab, M., Lesner, A., Banecki, B., Skorko-Glonek, J., Joachimiak, A., and Lipinska, B. (2015). Structural and Functional Analysis of Human HtrA3 Protease and Its Subdomains. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131142"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nsb795","article-title":"Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2\/Omi","volume":"9","author":"Li","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nsmb.2013","article-title":"Substrate-induced remodeling of the active site regulates human HTRA1 activity","volume":"18","author":"Truebestein","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.placenta.2012.08.003","article-title":"Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia","volume":"33","author":"Inagaki","year":"2012","journal-title":"Placenta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E936","DOI":"10.1210\/jc.2014-3969","article-title":"Human HtrA4 Expression is Restricted to the Placenta, is Significantly Up-Regulated in Early-Onset Preeclampsia, and High Levels of HtrA4 Cause Endothelial Dysfunction","volume":"100","author":"Singh","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"22958","DOI":"10.1074\/jbc.M114.576744","article-title":"Functional antagonism between high temperature requirement protein A (HtrA) family members regulates trophoblast invasion","volume":"289","author":"Chen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dynon, K., Heng, S., Puryer, M., Li, Y., Walton, K., Endo, Y., and Nie, G. (2012). HtrA3 as an early marker for preeclampsia: Specific monoclonal antibodies and sensitive high-throughput assays for serum screening. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045956"},{"key":"ref_20","first-page":"2937","article-title":"Elevated HTRA1 and HTRA4 in severe preeclampsia and their roles in trophoblast functions","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/156800909788486704","article-title":"HtrA serine proteases as potential therapeutic targets in cancer","volume":"9","author":"Chien","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","article-title":"Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain","volume":"9","author":"Sun","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2006.01.013","article-title":"X chromosomal abnormalities in basal-like human breast cancer","volume":"9","author":"Richardson","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature05886","article-title":"Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers","volume":"447","author":"Maser","year":"2007","journal-title":"Nature"},{"key":"ref_26","first-page":"5058","article-title":"High levels of HtrA4 detected in preeclamptic circulation may disrupt endothelial cell function by cleaving the main VEGFA receptor KDR","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jprot.2018.02.022","article-title":"HtrA3 is a cellular partner of cytoskeleton proteins and TCP1\u03b1 chaperonin","volume":"177","author":"Wenta","year":"2018","journal-title":"J. Proteomics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1128\/MCB.00035-09","article-title":"Serine protease HtrA1 associates with microtubules and inhibits cell migration","volume":"29","author":"Chien","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1074\/jbc.M109.097790","article-title":"High temperature requirement A3 (HtrA3) promotes etoposide- and cisplatin-induced cytotoxicity in lung cancer cell lines","volume":"285","author":"Beleford","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI27698","article-title":"Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity","volume":"116","author":"Chien","year":"2006","journal-title":"J. Clin. Invest."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jcb.21804","article-title":"Intracellular localization of the tumor suppressor HtrA1\/Prss11 and its association with HPV16 E6 and E7 proteins","volume":"105","author":"Clawson","year":"2008","journal-title":"J. Cell Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bbrc.2007.07.053","article-title":"Mitochondrial import of Omi: The definitive role of the putative transmembrane region and multiple processing sites in the amino-terminal segment","volume":"361","author":"Kadomatsu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103505","DOI":"10.1016\/j.jprot.2019.103505","article-title":"Cellular substrates and pro-apoptotic function of the human HtrA4 protease","volume":"209","author":"Wenta","year":"2019","journal-title":"J. Proteomics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/jcb.24751","article-title":"HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties","volume":"115","author":"Xu","year":"2014","journal-title":"J. Cell Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1091\/mbc.e09-02-0174","article-title":"Glycogen synthase kinase-3 and Omi\/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis","volume":"20","author":"Wang","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1074\/jbc.M109784200","article-title":"The serine protease Omi\/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif","volume":"277","author":"Martins","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/cells2010163","article-title":"Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)","volume":"2","author":"Berthelet","year":"2013","journal-title":"Cells"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"40725","DOI":"10.18632\/oncotarget.9173","article-title":"High temperature requirement A3 (HTRA3) expression predicts postoperative recurrence and survival in patients with non-small-cell lung cancer","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2017.12.011","article-title":"HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease Model","volume":"27","author":"Melo","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/10\/1112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:22:08Z","timestamp":1760188928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/10\/1112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["cells8101112"],"URL":"https:\/\/doi.org\/10.3390\/cells8101112","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,20]]}}}